Global Cell Therapy CMO Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Cell Therapy CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell Therapy CMO.
The Cell Therapy CMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Therapy CMO market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy CMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cell Therapy CMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell Therapy CMO market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell Therapy CMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Charles River
- The Discovery Labs
- BIOCENTRIQ
- FUJIFILM Diosynth Biotechnologies
- Exothera
- WuXi AppTec
- Pharmaron
- OBiO
- Cell Therapies
- AGC Biologics
- Cytiva
- Helixmith
- ThermoGenesis
- Anemocyte
- Thermo Fisher Scientific
- CBM
- Bio Elpida
- Genezen
- CCRM
- RoslinCT
- GenScript ProBio
- Stem Cell
- Non-Stem Cell
- Commercial
- Academic Research
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell Therapy CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy CMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cell Therapy CMO Market Perspective (2018-2029)
2.2 Cell Therapy CMO Growth Trends by Region
2.2.1 Global Cell Therapy CMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Therapy CMO Historic Market Size by Region (2018-2023)
2.2.3 Cell Therapy CMO Forecasted Market Size by Region (2024-2029)
2.3 Cell Therapy CMO Market Dynamics
2.3.1 Cell Therapy CMO Industry Trends
2.3.2 Cell Therapy CMO Market Drivers
2.3.3 Cell Therapy CMO Market Challenges
2.3.4 Cell Therapy CMO Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell Therapy CMO Players by Revenue
3.1.1 Global Top Cell Therapy CMO Players by Revenue (2018-2023)
3.1.2 Global Cell Therapy CMO Revenue Market Share by Players (2018-2023)
3.2 Global Cell Therapy CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy CMO Revenue
3.4 Global Cell Therapy CMO Market Concentration Ratio
3.4.1 Global Cell Therapy CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CMO Revenue in 2022
3.5 Cell Therapy CMO Key Players Head office and Area Served
3.6 Key Players Cell Therapy CMO Product Solution and Service
3.7 Date of Enter into Cell Therapy CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CELL THERAPY CMO BREAKDOWN DATA BY TYPE
4.1 Global Cell Therapy CMO Historic Market Size by Type (2018-2023)
4.2 Global Cell Therapy CMO Forecasted Market Size by Type (2024-2029)
5 CELL THERAPY CMO BREAKDOWN DATA BY APPLICATION
5.1 Global Cell Therapy CMO Historic Market Size by Application (2018-2023)
5.2 Global Cell Therapy CMO Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell Therapy CMO Market Size (2018-2029)
6.2 North America Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Therapy CMO Market Size by Country (2018-2023)
6.4 North America Cell Therapy CMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cell Therapy CMO Market Size (2018-2029)
7.2 Europe Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Therapy CMO Market Size by Country (2018-2023)
7.4 Europe Cell Therapy CMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell Therapy CMO Market Size (2018-2029)
8.2 Asia-Pacific Cell Therapy CMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Therapy CMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Therapy CMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cell Therapy CMO Market Size (2018-2029)
9.2 Latin America Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Therapy CMO Market Size by Country (2018-2023)
9.4 Latin America Cell Therapy CMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell Therapy CMO Market Size (2018-2029)
10.2 Middle East & Africa Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Therapy CMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Therapy CMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Therapy CMO Introduction
11.1.4 Charles River Revenue in Cell Therapy CMO Business (2018-2023)
11.1.5 Charles River Recent Development
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Detail
11.2.2 The Discovery Labs Business Overview
11.2.3 The Discovery Labs Cell Therapy CMO Introduction
11.2.4 The Discovery Labs Revenue in Cell Therapy CMO Business (2018-2023)
11.2.5 The Discovery Labs Recent Development
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Detail
11.3.2 BIOCENTRIQ Business Overview
11.3.3 BIOCENTRIQ Cell Therapy CMO Introduction
11.3.4 BIOCENTRIQ Revenue in Cell Therapy CMO Business (2018-2023)
11.3.5 BIOCENTRIQ Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2018-2023)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Exothera
11.5.1 Exothera Company Detail
11.5.2 Exothera Business Overview
11.5.3 Exothera Cell Therapy CMO Introduction
11.5.4 Exothera Revenue in Cell Therapy CMO Business (2018-2023)
11.5.5 Exothera Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell Therapy CMO Introduction
11.6.4 WuXi AppTec Revenue in Cell Therapy CMO Business (2018-2023)
11.6.5 WuXi AppTec Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Detail
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Cell Therapy CMO Introduction
11.7.4 Pharmaron Revenue in Cell Therapy CMO Business (2018-2023)
11.7.5 Pharmaron Recent Development
11.8 OBiO
11.8.1 OBiO Company Detail
11.8.2 OBiO Business Overview
11.8.3 OBiO Cell Therapy CMO Introduction
11.8.4 OBiO Revenue in Cell Therapy CMO Business (2018-2023)
11.8.5 OBiO Recent Development
11.9 Cell Therapies
11.9.1 Cell Therapies Company Detail
11.9.2 Cell Therapies Business Overview
11.9.3 Cell Therapies Cell Therapy CMO Introduction
11.9.4 Cell Therapies Revenue in Cell Therapy CMO Business (2018-2023)
11.9.5 Cell Therapies Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Detail
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Cell Therapy CMO Introduction
11.10.4 AGC Biologics Revenue in Cell Therapy CMO Business (2018-2023)
11.10.5 AGC Biologics Recent Development
11.11 Cytiva
11.11.1 Cytiva Company Detail
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Cell Therapy CMO Introduction
11.11.4 Cytiva Revenue in Cell Therapy CMO Business (2018-2023)
11.11.5 Cytiva Recent Development
11.12 Helixmith
11.12.1 Helixmith Company Detail
11.12.2 Helixmith Business Overview
11.12.3 Helixmith Cell Therapy CMO Introduction
11.12.4 Helixmith Revenue in Cell Therapy CMO Business (2018-2023)
11.12.5 Helixmith Recent Development
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Detail
11.13.2 ThermoGenesis Business Overview
11.13.3 ThermoGenesis Cell Therapy CMO Introduction
11.13.4 ThermoGenesis Revenue in Cell Therapy CMO Business (2018-2023)
11.13.5 ThermoGenesis Recent Development
11.14 Anemocyte
11.14.1 Anemocyte Company Detail
11.14.2 Anemocyte Business Overview
11.14.3 Anemocyte Cell Therapy CMO Introduction
11.14.4 Anemocyte Revenue in Cell Therapy CMO Business (2018-2023)
11.14.5 Anemocyte Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Cell Therapy CMO Introduction
11.15.4 Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2018-2023)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 CBM
11.16.1 CBM Company Detail
11.16.2 CBM Business Overview
11.16.3 CBM Cell Therapy CMO Introduction
11.16.4 CBM Revenue in Cell Therapy CMO Business (2018-2023)
11.16.5 CBM Recent Development
11.17 Bio Elpida
11.17.1 Bio Elpida Company Detail
11.17.2 Bio Elpida Business Overview
11.17.3 Bio Elpida Cell Therapy CMO Introduction
11.17.4 Bio Elpida Revenue in Cell Therapy CMO Business (2018-2023)
11.17.5 Bio Elpida Recent Development
11.18 Genezen
11.18.1 Genezen Company Detail
11.18.2 Genezen Business Overview
11.18.3 Genezen Cell Therapy CMO Introduction
11.18.4 Genezen Revenue in Cell Therapy CMO Business (2018-2023)
11.18.5 Genezen Recent Development
11.19 CCRM
11.19.1 CCRM Company Detail
11.19.2 CCRM Business Overview
11.19.3 CCRM Cell Therapy CMO Introduction
11.19.4 CCRM Revenue in Cell Therapy CMO Business (2018-2023)
11.19.5 CCRM Recent Development
11.20 RoslinCT
11.20.1 RoslinCT Company Detail
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy CMO Introduction
11.20.4 RoslinCT Revenue in Cell Therapy CMO Business (2018-2023)
11.20.5 RoslinCT Recent Development
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Detail
11.21.2 GenScript ProBio Business Overview
11.21.3 GenScript ProBio Cell Therapy CMO Introduction
11.21.4 GenScript ProBio Revenue in Cell Therapy CMO Business (2018-2023)
11.21.5 GenScript ProBio Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy CMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market by Application
1.3.1 Global Cell Therapy CMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cell Therapy CMO Market Perspective (2018-2029)
2.2 Cell Therapy CMO Growth Trends by Region
2.2.1 Global Cell Therapy CMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell Therapy CMO Historic Market Size by Region (2018-2023)
2.2.3 Cell Therapy CMO Forecasted Market Size by Region (2024-2029)
2.3 Cell Therapy CMO Market Dynamics
2.3.1 Cell Therapy CMO Industry Trends
2.3.2 Cell Therapy CMO Market Drivers
2.3.3 Cell Therapy CMO Market Challenges
2.3.4 Cell Therapy CMO Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell Therapy CMO Players by Revenue
3.1.1 Global Top Cell Therapy CMO Players by Revenue (2018-2023)
3.1.2 Global Cell Therapy CMO Revenue Market Share by Players (2018-2023)
3.2 Global Cell Therapy CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Therapy CMO Revenue
3.4 Global Cell Therapy CMO Market Concentration Ratio
3.4.1 Global Cell Therapy CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Therapy CMO Revenue in 2022
3.5 Cell Therapy CMO Key Players Head office and Area Served
3.6 Key Players Cell Therapy CMO Product Solution and Service
3.7 Date of Enter into Cell Therapy CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CELL THERAPY CMO BREAKDOWN DATA BY TYPE
4.1 Global Cell Therapy CMO Historic Market Size by Type (2018-2023)
4.2 Global Cell Therapy CMO Forecasted Market Size by Type (2024-2029)
5 CELL THERAPY CMO BREAKDOWN DATA BY APPLICATION
5.1 Global Cell Therapy CMO Historic Market Size by Application (2018-2023)
5.2 Global Cell Therapy CMO Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell Therapy CMO Market Size (2018-2029)
6.2 North America Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell Therapy CMO Market Size by Country (2018-2023)
6.4 North America Cell Therapy CMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cell Therapy CMO Market Size (2018-2029)
7.2 Europe Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell Therapy CMO Market Size by Country (2018-2023)
7.4 Europe Cell Therapy CMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell Therapy CMO Market Size (2018-2029)
8.2 Asia-Pacific Cell Therapy CMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell Therapy CMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell Therapy CMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cell Therapy CMO Market Size (2018-2029)
9.2 Latin America Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell Therapy CMO Market Size by Country (2018-2023)
9.4 Latin America Cell Therapy CMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell Therapy CMO Market Size (2018-2029)
10.2 Middle East & Africa Cell Therapy CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell Therapy CMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell Therapy CMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Cell Therapy CMO Introduction
11.1.4 Charles River Revenue in Cell Therapy CMO Business (2018-2023)
11.1.5 Charles River Recent Development
11.2 The Discovery Labs
11.2.1 The Discovery Labs Company Detail
11.2.2 The Discovery Labs Business Overview
11.2.3 The Discovery Labs Cell Therapy CMO Introduction
11.2.4 The Discovery Labs Revenue in Cell Therapy CMO Business (2018-2023)
11.2.5 The Discovery Labs Recent Development
11.3 BIOCENTRIQ
11.3.1 BIOCENTRIQ Company Detail
11.3.2 BIOCENTRIQ Business Overview
11.3.3 BIOCENTRIQ Cell Therapy CMO Introduction
11.3.4 BIOCENTRIQ Revenue in Cell Therapy CMO Business (2018-2023)
11.3.5 BIOCENTRIQ Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2018-2023)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Exothera
11.5.1 Exothera Company Detail
11.5.2 Exothera Business Overview
11.5.3 Exothera Cell Therapy CMO Introduction
11.5.4 Exothera Revenue in Cell Therapy CMO Business (2018-2023)
11.5.5 Exothera Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell Therapy CMO Introduction
11.6.4 WuXi AppTec Revenue in Cell Therapy CMO Business (2018-2023)
11.6.5 WuXi AppTec Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Detail
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Cell Therapy CMO Introduction
11.7.4 Pharmaron Revenue in Cell Therapy CMO Business (2018-2023)
11.7.5 Pharmaron Recent Development
11.8 OBiO
11.8.1 OBiO Company Detail
11.8.2 OBiO Business Overview
11.8.3 OBiO Cell Therapy CMO Introduction
11.8.4 OBiO Revenue in Cell Therapy CMO Business (2018-2023)
11.8.5 OBiO Recent Development
11.9 Cell Therapies
11.9.1 Cell Therapies Company Detail
11.9.2 Cell Therapies Business Overview
11.9.3 Cell Therapies Cell Therapy CMO Introduction
11.9.4 Cell Therapies Revenue in Cell Therapy CMO Business (2018-2023)
11.9.5 Cell Therapies Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Detail
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Cell Therapy CMO Introduction
11.10.4 AGC Biologics Revenue in Cell Therapy CMO Business (2018-2023)
11.10.5 AGC Biologics Recent Development
11.11 Cytiva
11.11.1 Cytiva Company Detail
11.11.2 Cytiva Business Overview
11.11.3 Cytiva Cell Therapy CMO Introduction
11.11.4 Cytiva Revenue in Cell Therapy CMO Business (2018-2023)
11.11.5 Cytiva Recent Development
11.12 Helixmith
11.12.1 Helixmith Company Detail
11.12.2 Helixmith Business Overview
11.12.3 Helixmith Cell Therapy CMO Introduction
11.12.4 Helixmith Revenue in Cell Therapy CMO Business (2018-2023)
11.12.5 Helixmith Recent Development
11.13 ThermoGenesis
11.13.1 ThermoGenesis Company Detail
11.13.2 ThermoGenesis Business Overview
11.13.3 ThermoGenesis Cell Therapy CMO Introduction
11.13.4 ThermoGenesis Revenue in Cell Therapy CMO Business (2018-2023)
11.13.5 ThermoGenesis Recent Development
11.14 Anemocyte
11.14.1 Anemocyte Company Detail
11.14.2 Anemocyte Business Overview
11.14.3 Anemocyte Cell Therapy CMO Introduction
11.14.4 Anemocyte Revenue in Cell Therapy CMO Business (2018-2023)
11.14.5 Anemocyte Recent Development
11.15 Thermo Fisher Scientific
11.15.1 Thermo Fisher Scientific Company Detail
11.15.2 Thermo Fisher Scientific Business Overview
11.15.3 Thermo Fisher Scientific Cell Therapy CMO Introduction
11.15.4 Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2018-2023)
11.15.5 Thermo Fisher Scientific Recent Development
11.16 CBM
11.16.1 CBM Company Detail
11.16.2 CBM Business Overview
11.16.3 CBM Cell Therapy CMO Introduction
11.16.4 CBM Revenue in Cell Therapy CMO Business (2018-2023)
11.16.5 CBM Recent Development
11.17 Bio Elpida
11.17.1 Bio Elpida Company Detail
11.17.2 Bio Elpida Business Overview
11.17.3 Bio Elpida Cell Therapy CMO Introduction
11.17.4 Bio Elpida Revenue in Cell Therapy CMO Business (2018-2023)
11.17.5 Bio Elpida Recent Development
11.18 Genezen
11.18.1 Genezen Company Detail
11.18.2 Genezen Business Overview
11.18.3 Genezen Cell Therapy CMO Introduction
11.18.4 Genezen Revenue in Cell Therapy CMO Business (2018-2023)
11.18.5 Genezen Recent Development
11.19 CCRM
11.19.1 CCRM Company Detail
11.19.2 CCRM Business Overview
11.19.3 CCRM Cell Therapy CMO Introduction
11.19.4 CCRM Revenue in Cell Therapy CMO Business (2018-2023)
11.19.5 CCRM Recent Development
11.20 RoslinCT
11.20.1 RoslinCT Company Detail
11.20.2 RoslinCT Business Overview
11.20.3 RoslinCT Cell Therapy CMO Introduction
11.20.4 RoslinCT Revenue in Cell Therapy CMO Business (2018-2023)
11.20.5 RoslinCT Recent Development
11.21 GenScript ProBio
11.21.1 GenScript ProBio Company Detail
11.21.2 GenScript ProBio Business Overview
11.21.3 GenScript ProBio Cell Therapy CMO Introduction
11.21.4 GenScript ProBio Revenue in Cell Therapy CMO Business (2018-2023)
11.21.5 GenScript ProBio Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Cell Therapy CMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Stem Cell
Table 3. Key Players of Non-Stem Cell
Table 4. Global Cell Therapy CMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cell Therapy CMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cell Therapy CMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Therapy CMO Market Share by Region (2018-2023)
Table 8. Global Cell Therapy CMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cell Therapy CMO Market Share by Region (2024-2029)
Table 10. Cell Therapy CMO Market Trends
Table 11. Cell Therapy CMO Market Drivers
Table 12. Cell Therapy CMO Market Challenges
Table 13. Cell Therapy CMO Market Restraints
Table 14. Global Cell Therapy CMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Therapy CMO Market Share by Players (2018-2023)
Table 16. Global Top Cell Therapy CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2022)
Table 17. Ranking of Global Top Cell Therapy CMO Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cell Therapy CMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy CMO Product Solution and Service
Table 21. Date of Enter into Cell Therapy CMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Therapy CMO Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Therapy CMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cell Therapy CMO Revenue Market Share by Type (2024-2029)
Table 27. Global Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Therapy CMO Revenue Market Share by Application (2018-2023)
Table 29. Global Cell Therapy CMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cell Therapy CMO Revenue Market Share by Application (2024-2029)
Table 31. North America Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cell Therapy CMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cell Therapy CMO Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cell Therapy CMO Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 46. Charles River Company Detail
Table 47. Charles River Business Overview
Table 48. Charles River Cell Therapy CMO Product
Table 49. Charles River Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. The Discovery Labs Company Detail
Table 52. The Discovery Labs Business Overview
Table 53. The Discovery Labs Cell Therapy CMO Product
Table 54. The Discovery Labs Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 55. The Discovery Labs Recent Development
Table 56. BIOCENTRIQ Company Detail
Table 57. BIOCENTRIQ Business Overview
Table 58. BIOCENTRIQ Cell Therapy CMO Product
Table 59. BIOCENTRIQ Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 60. BIOCENTRIQ Recent Development
Table 61. FUJIFILM Diosynth Biotechnologies Company Detail
Table 62. FUJIFILM Diosynth Biotechnologies Business Overview
Table 63. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product
Table 64. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 65. FUJIFILM Diosynth Biotechnologies Recent Development
Table 66. Exothera Company Detail
Table 67. Exothera Business Overview
Table 68. Exothera Cell Therapy CMO Product
Table 69. Exothera Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 70. Exothera Recent Development
Table 71. WuXi AppTec Company Detail
Table 72. WuXi AppTec Business Overview
Table 73. WuXi AppTec Cell Therapy CMO Product
Table 74. WuXi AppTec Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 75. WuXi AppTec Recent Development
Table 76. Pharmaron Company Detail
Table 77. Pharmaron Business Overview
Table 78. Pharmaron Cell Therapy CMO Product
Table 79. Pharmaron Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 80. Pharmaron Recent Development
Table 81. OBiO Company Detail
Table 82. OBiO Business Overview
Table 83. OBiO Cell Therapy CMO Product
Table 84. OBiO Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 85. OBiO Recent Development
Table 86. Cell Therapies Company Detail
Table 87. Cell Therapies Business Overview
Table 88. Cell Therapies Cell Therapy CMO Product
Table 89. Cell Therapies Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 90. Cell Therapies Recent Development
Table 91. AGC Biologics Company Detail
Table 92. AGC Biologics Business Overview
Table 93. AGC Biologics Cell Therapy CMO Product
Table 94. AGC Biologics Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 95. AGC Biologics Recent Development
Table 96. Cytiva Company Detail
Table 97. Cytiva Business Overview
Table 98. Cytiva Cell Therapy CMO Product
Table 99. Cytiva Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 100. Cytiva Recent Development
Table 101. Helixmith Company Detail
Table 102. Helixmith Business Overview
Table 103. Helixmith Cell Therapy CMO Product
Table 104. Helixmith Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 105. Helixmith Recent Development
Table 106. ThermoGenesis Company Detail
Table 107. ThermoGenesis Business Overview
Table 108. ThermoGenesis Cell Therapy CMO Product
Table 109. ThermoGenesis Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 110. ThermoGenesis Recent Development
Table 111. Anemocyte Company Detail
Table 112. Anemocyte Business Overview
Table 113. Anemocyte Cell Therapy CMO Product
Table 114. Anemocyte Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 115. Anemocyte Recent Development
Table 116. Thermo Fisher Scientific Company Detail
Table 117. Thermo Fisher Scientific Business Overview
Table 118. Thermo Fisher Scientific Cell Therapy CMO Product
Table 119. Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 120. Thermo Fisher Scientific Recent Development
Table 121. CBM Company Detail
Table 122. CBM Business Overview
Table 123. CBM Cell Therapy CMO Product
Table 124. CBM Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 125. CBM Recent Development
Table 126. Bio Elpida Company Detail
Table 127. Bio Elpida Business Overview
Table 128. Bio Elpida Cell Therapy CMO Product
Table 129. Bio Elpida Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 130. Bio Elpida Recent Development
Table 131. Genezen Company Detail
Table 132. Genezen Business Overview
Table 133. Genezen Cell Therapy CMO Product
Table 134. Genezen Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 135. Genezen Recent Development
Table 136. CCRM Company Detail
Table 137. CCRM Business Overview
Table 138. CCRM Cell Therapy CMO Product
Table 139. CCRM Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 140. CCRM Recent Development
Table 141. RoslinCT Company Detail
Table 142. RoslinCT Business Overview
Table 143. RoslinCT Cell Therapy CMO Product
Table 144. RoslinCT Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 145. RoslinCT Recent Development
Table 146. GenScript ProBio Company Detail
Table 147. GenScript ProBio Business Overview
Table 148. GenScript ProBio Cell Therapy CMO Product
Table 149. GenScript ProBio Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 150. GenScript ProBio Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 1. Global Cell Therapy CMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Stem Cell
Table 3. Key Players of Non-Stem Cell
Table 4. Global Cell Therapy CMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Cell Therapy CMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cell Therapy CMO Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Cell Therapy CMO Market Share by Region (2018-2023)
Table 8. Global Cell Therapy CMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Cell Therapy CMO Market Share by Region (2024-2029)
Table 10. Cell Therapy CMO Market Trends
Table 11. Cell Therapy CMO Market Drivers
Table 12. Cell Therapy CMO Market Challenges
Table 13. Cell Therapy CMO Market Restraints
Table 14. Global Cell Therapy CMO Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Cell Therapy CMO Market Share by Players (2018-2023)
Table 16. Global Top Cell Therapy CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2022)
Table 17. Ranking of Global Top Cell Therapy CMO Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Cell Therapy CMO Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cell Therapy CMO Product Solution and Service
Table 21. Date of Enter into Cell Therapy CMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cell Therapy CMO Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Cell Therapy CMO Revenue Market Share by Type (2018-2023)
Table 25. Global Cell Therapy CMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Cell Therapy CMO Revenue Market Share by Type (2024-2029)
Table 27. Global Cell Therapy CMO Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Cell Therapy CMO Revenue Market Share by Application (2018-2023)
Table 29. Global Cell Therapy CMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Cell Therapy CMO Revenue Market Share by Application (2024-2029)
Table 31. North America Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Cell Therapy CMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Cell Therapy CMO Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Cell Therapy CMO Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Cell Therapy CMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Cell Therapy CMO Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Cell Therapy CMO Market Size by Country (2024-2029) & (US$ Million)
Table 46. Charles River Company Detail
Table 47. Charles River Business Overview
Table 48. Charles River Cell Therapy CMO Product
Table 49. Charles River Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. The Discovery Labs Company Detail
Table 52. The Discovery Labs Business Overview
Table 53. The Discovery Labs Cell Therapy CMO Product
Table 54. The Discovery Labs Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 55. The Discovery Labs Recent Development
Table 56. BIOCENTRIQ Company Detail
Table 57. BIOCENTRIQ Business Overview
Table 58. BIOCENTRIQ Cell Therapy CMO Product
Table 59. BIOCENTRIQ Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 60. BIOCENTRIQ Recent Development
Table 61. FUJIFILM Diosynth Biotechnologies Company Detail
Table 62. FUJIFILM Diosynth Biotechnologies Business Overview
Table 63. FUJIFILM Diosynth Biotechnologies Cell Therapy CMO Product
Table 64. FUJIFILM Diosynth Biotechnologies Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 65. FUJIFILM Diosynth Biotechnologies Recent Development
Table 66. Exothera Company Detail
Table 67. Exothera Business Overview
Table 68. Exothera Cell Therapy CMO Product
Table 69. Exothera Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 70. Exothera Recent Development
Table 71. WuXi AppTec Company Detail
Table 72. WuXi AppTec Business Overview
Table 73. WuXi AppTec Cell Therapy CMO Product
Table 74. WuXi AppTec Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 75. WuXi AppTec Recent Development
Table 76. Pharmaron Company Detail
Table 77. Pharmaron Business Overview
Table 78. Pharmaron Cell Therapy CMO Product
Table 79. Pharmaron Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 80. Pharmaron Recent Development
Table 81. OBiO Company Detail
Table 82. OBiO Business Overview
Table 83. OBiO Cell Therapy CMO Product
Table 84. OBiO Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 85. OBiO Recent Development
Table 86. Cell Therapies Company Detail
Table 87. Cell Therapies Business Overview
Table 88. Cell Therapies Cell Therapy CMO Product
Table 89. Cell Therapies Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 90. Cell Therapies Recent Development
Table 91. AGC Biologics Company Detail
Table 92. AGC Biologics Business Overview
Table 93. AGC Biologics Cell Therapy CMO Product
Table 94. AGC Biologics Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 95. AGC Biologics Recent Development
Table 96. Cytiva Company Detail
Table 97. Cytiva Business Overview
Table 98. Cytiva Cell Therapy CMO Product
Table 99. Cytiva Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 100. Cytiva Recent Development
Table 101. Helixmith Company Detail
Table 102. Helixmith Business Overview
Table 103. Helixmith Cell Therapy CMO Product
Table 104. Helixmith Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 105. Helixmith Recent Development
Table 106. ThermoGenesis Company Detail
Table 107. ThermoGenesis Business Overview
Table 108. ThermoGenesis Cell Therapy CMO Product
Table 109. ThermoGenesis Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 110. ThermoGenesis Recent Development
Table 111. Anemocyte Company Detail
Table 112. Anemocyte Business Overview
Table 113. Anemocyte Cell Therapy CMO Product
Table 114. Anemocyte Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 115. Anemocyte Recent Development
Table 116. Thermo Fisher Scientific Company Detail
Table 117. Thermo Fisher Scientific Business Overview
Table 118. Thermo Fisher Scientific Cell Therapy CMO Product
Table 119. Thermo Fisher Scientific Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 120. Thermo Fisher Scientific Recent Development
Table 121. CBM Company Detail
Table 122. CBM Business Overview
Table 123. CBM Cell Therapy CMO Product
Table 124. CBM Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 125. CBM Recent Development
Table 126. Bio Elpida Company Detail
Table 127. Bio Elpida Business Overview
Table 128. Bio Elpida Cell Therapy CMO Product
Table 129. Bio Elpida Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 130. Bio Elpida Recent Development
Table 131. Genezen Company Detail
Table 132. Genezen Business Overview
Table 133. Genezen Cell Therapy CMO Product
Table 134. Genezen Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 135. Genezen Recent Development
Table 136. CCRM Company Detail
Table 137. CCRM Business Overview
Table 138. CCRM Cell Therapy CMO Product
Table 139. CCRM Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 140. CCRM Recent Development
Table 141. RoslinCT Company Detail
Table 142. RoslinCT Business Overview
Table 143. RoslinCT Cell Therapy CMO Product
Table 144. RoslinCT Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 145. RoslinCT Recent Development
Table 146. GenScript ProBio Company Detail
Table 147. GenScript ProBio Business Overview
Table 148. GenScript ProBio Cell Therapy CMO Product
Table 149. GenScript ProBio Revenue in Cell Therapy CMO Business (2018-2023) & (US$ Million)
Table 150. GenScript ProBio Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cell Therapy CMO Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell Therapy CMO Market Share by Type: 2022 VS 2029
Figure 3. Stem Cell Features
Figure 4. Non-Stem Cell Features
Figure 5. Global Cell Therapy CMO Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cell Therapy CMO Market Share by Application: 2022 VS 2029
Figure 7. Commercial Case Studies
Figure 8. Academic Research Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy CMO Report Years Considered
Figure 11. Global Cell Therapy CMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Cell Therapy CMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Cell Therapy CMO Market Share by Region: 2022 VS 2029
Figure 14. Global Cell Therapy CMO Market Share by Players in 2022
Figure 15. Global Top Cell Therapy CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy CMO Revenue in 2022
Figure 17. North America Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Cell Therapy CMO Market Share by Country (2018-2029)
Figure 19. United States Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cell Therapy CMO Market Share by Country (2018-2029)
Figure 23. Germany Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cell Therapy CMO Market Share by Region (2018-2029)
Figure 31. China Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cell Therapy CMO Market Share by Country (2018-2029)
Figure 39. Mexico Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cell Therapy CMO Market Share by Country (2018-2029)
Figure 43. Turkey Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Charles River Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 46. The Discovery Labs Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 47. BIOCENTRIQ Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 48. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 49. Exothera Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 50. WuXi AppTec Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 51. Pharmaron Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 52. OBiO Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 53. Cell Therapies Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 54. AGC Biologics Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 55. Cytiva Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 56. Helixmith Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 57. ThermoGenesis Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 58. Anemocyte Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 60. CBM Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 61. Bio Elpida Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 62. Genezen Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 63. CCRM Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 64. RoslinCT Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 65. GenScript ProBio Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global Cell Therapy CMO Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell Therapy CMO Market Share by Type: 2022 VS 2029
Figure 3. Stem Cell Features
Figure 4. Non-Stem Cell Features
Figure 5. Global Cell Therapy CMO Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Cell Therapy CMO Market Share by Application: 2022 VS 2029
Figure 7. Commercial Case Studies
Figure 8. Academic Research Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Therapy CMO Report Years Considered
Figure 11. Global Cell Therapy CMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Cell Therapy CMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Cell Therapy CMO Market Share by Region: 2022 VS 2029
Figure 14. Global Cell Therapy CMO Market Share by Players in 2022
Figure 15. Global Top Cell Therapy CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy CMO as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Cell Therapy CMO Revenue in 2022
Figure 17. North America Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Cell Therapy CMO Market Share by Country (2018-2029)
Figure 19. United States Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cell Therapy CMO Market Share by Country (2018-2029)
Figure 23. Germany Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cell Therapy CMO Market Share by Region (2018-2029)
Figure 31. China Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cell Therapy CMO Market Share by Country (2018-2029)
Figure 39. Mexico Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cell Therapy CMO Market Share by Country (2018-2029)
Figure 43. Turkey Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Cell Therapy CMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Charles River Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 46. The Discovery Labs Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 47. BIOCENTRIQ Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 48. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 49. Exothera Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 50. WuXi AppTec Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 51. Pharmaron Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 52. OBiO Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 53. Cell Therapies Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 54. AGC Biologics Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 55. Cytiva Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 56. Helixmith Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 57. ThermoGenesis Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 58. Anemocyte Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 60. CBM Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 61. Bio Elpida Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 62. Genezen Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 63. CCRM Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 64. RoslinCT Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 65. GenScript ProBio Revenue Growth Rate in Cell Therapy CMO Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
